Browse by category

Metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage...

A new experimental anti-obesity drug, Growth Differentiation Factor 15 (GDF15), improves diastolic heart function in mice with type 2...

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events (MACE) among people...

Semaglutide significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options....

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

New research has debunked the idea that there is an “obesity paradox”, whereby patients with heart failure who are overweight or obese...

Adults with obesity but who otherwise appear healthy without common metabolic abnormalities such as high blood pressure, abnormal blood...